Brain’s CGRP Switch Flips Fear Response from Freezing to Active Escape

A single population of neurons in the brainstem may determine whether an animal confronted with danger freezes in place or actively runs for safety. A study published in NPJ Science of Learning reports that inhibiting the neuropeptide calcitonin gene-related peptide, or CGRP, within the parabrachial nucleus shifts defensive behavior away from passive immobility and toward active avoidance, using a platform-based avoidance paradigm that allowed researchers to track the moment-to-moment strategy an animal chooses under threat. The finding adds a critical piece to a long-standing puzzle in neuroscience: how the brain decides which of its many available defensive programs to deploy when survival is on the line.

The parabrachial nucleus, a compact structure tucked into the dorsolateral pons, has long been recognized as a major relay station for alarm signals traveling from the body and spinal cord up to forebrain circuits. CGRP-expressing neurons in this region project densely to the central amygdala, the bed nucleus of the stria terminalis and other threat-processing hubs, and earlier work established that artificially activating these neurons produces powerful aversive states and widespread fear-like responses. What remained less clear was whether CGRP signaling in the parabrachial nucleus influences not just the intensity of fear, but the specific behavioral form that fear takes, an issue the new study set out to address directly.

To do so, the researchers employed a platform-based active avoidance paradigm, an experimental setup in which a rodent can terminate or avoid an aversive stimulus by moving onto a raised platform. Unlike classical Pavlovian fear-conditioning assays, which measure freezing as the primary output, active avoidance tasks capture the animal’s capacity to translate threat detection into goal-directed escape behavior. This distinction is crucial, because freezing and active avoidance are not simply different intensities of the same response; they represent distinct defensive strategies governed by partially separable neural circuits, and animals typically select between them based on factors such as the distance to the threat, the availability of escape routes and previous experience with the environment.

The central manipulation involved pharmacological or chemogenetic inhibition of CGRP signaling within the parabrachial nucleus. When CGRP activity was suppressed, the researchers observed a striking reorganization of defensive behavior: animals spent less time in the passive, immobile freezing posture that normally dominates their response to learned threat cues, and instead escalated their engagement with the active avoidance strategy, rapidly locating and mounting the escape platform. In other words, dampening CGRP did not blunt fear altogether, as one might naively predict if the peptide were simply a universal fear amplifier. Rather, it redirected the defensive response, channeling the animal’s motivational energy from one stereotyped strategy into another.

This dissociation carries substantial theoretical weight. Classical models of fear conditioning have often treated freezing as the canonical index of conditioned fear, so much so that a pharmacological intervention reducing freezing would conventionally be interpreted as anxiolytic or fear-reducing. The new results challenge that inference. Animals with inhibited parabrachial CGRP signaling were not less afraid; they were differently afraid, mobilizing an active coping strategy in place of an immobile one. The study therefore reinforces an increasingly influential view in behavioral neuroscience: that fear must be measured across a repertoire of adaptive responses, and that single-measure assays can systematically mischaracterize the effects of neural or pharmacological manipulations.

From a mechanistic standpoint, the findings suggest that CGRP neurons in the parabrachial nucleus act as a biasing signal within a distributed defensive decision network. These neurons are well positioned for such a role. They integrate interoceptive alarm signals, including those carried by the spinal trigeminal and lamina I spinothalamic pathways, and broadcast the resulting arousal state to forebrain structures that execute specific defensive programs. Projections to the central amygdala have been implicated in promoting passive defensive reactions, whereas circuits running through the ventrolateral periaqueductal gray and basal ganglia loops are more closely associated with active escape and avoidance. By altering the gain of CGRP signaling at the source, the manipulation appears to rebalance competition between these downstream effectors, tilting the system toward the active option.

The platform-based paradigm proved especially informative because it allowed within-subject quantification of both response types. Rather than relying on separate cohorts of freezing-conditioned and shuttle-box-trained animals, the researchers could observe individual animals distributing their behavior between immobility and platform escape across trials. This design revealed that the shift from freezing to avoidance was not a threshold artifact or a byproduct of altered shock sensitivity; instead, it reflected a genuine reweighting of strategy selection, consistent with a decision-level function for parabrachial CGRP rather than a purely sensory or motor role.

The translational implications are significant, particularly for post-traumatic stress disorder and other trauma- and anxiety-related conditions in which patients exhibit maladaptive defensive postures. Human PTSD is often characterized not only by exaggerated fear responses but by inflexibility in choosing among coping strategies, including a failure to engage active avoidance or escape behaviors that might reduce harm. If CGRP signaling in the parabrachial-amygdala pathway similarly constrains active coping in humans, drugs that modulate CGRP receptors, a class already developed and clinically validated for migraine prophylaxis through gepant compounds, could conceivably be repurposed or re-evaluated for their effects on defensive strategy selection. The new study does not establish such clinical effects, but it provides a rigorous animal-model foundation for asking the question.

More broadly, the work exemplifies a shift in how learning and memory research frames threat-related behavior. Instead of treating fear as a unitary internal state read out through a single behavioral channel, contemporary neuroscience increasingly emphasizes a menu of genetically and anatomically specified defensive circuits whose relative activation determines the observable strategy. CGRP neurons in the parabrachial nucleus now appear to be one of the clearest molecularly identifiable control points for that selection process. By demonstrating that inhibition of this specific neuropeptide population reconfigures, rather than diminishes, defensive behavior, the study offers both a conceptual lesson, that fear research must account for strategy switching, and a practical one, that assays capturing active coping are indispensable for interpreting interventions aimed at threat-related circuitry. As attention turns to how upstream inputs and downstream targets partition the freezing-versus-avoidance decision, the parabrachial CGRP system is likely to remain a focal point for understanding how brains choose how to be afraid.

Subject of Research: Role of CGRP neurons in the parabrachial nucleus in selecting between freezing and active avoidance defensive strategies

Article Title: CGRP inhibition in the PBN shifts defensive strategy from freezing to active avoidance in a platform-based active avoidance paradigm

Article References: CGRP inhibition in the PBN shifts defensive strategy from freezing to active avoidance in a platform-based active avoidance paradigm. (n.d.). https://doi.org/10.1038/s41539-026-00453-3

Image Credits: AI Generated

DOI: 10.1038/s41539-026-00453-3

Keywords: CGRP, parabrachial nucleus, active avoidance, freezing, fear conditioning, defensive behavior, threat processing, amygdala, neuropeptides, behavioral neuroscience, PTSD, platform-based avoidance paradigm